Browse by Person

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 5.

Article

Collett, L, Howard, DR orcid.org/0000-0003-3333-9783, Munir, T et al. (11 more authors) (2017) Assessment of ibrutinib plus rituximab in front-line CLL (FLAIR trial): study protocol for a phase III randomised controlled trial. Trials, 18. 387. ISSN 1745-6215

Oughton, JB orcid.org/0000-0002-2047-804X, Road, H, Twiddy, M orcid.org/0000-0002-3794-1598 et al. (13 more authors) (2017) Radical cystectomy (bladder removal) against intravesical BCG immunotherapy for high-risk nonmuscle invasive bladder cancer (BRAVO): a protocol for a randomised controlled feasibility study. BMJ Open, 7 (8). e017913. ISSN 2044-6055

Oughton, JB orcid.org/0000-0002-2047-804X, Collett, L, Howard, DR orcid.org/0000-0003-3333-9783 et al. (8 more authors) (2017) GA101 (obinutuzumab) monocLonal Antibody as Consolidation Therapy In CLL (GALACTIC) trial: study protocol for a phase II/III randomised controlled trial. Trials, 18. 353. ISSN 1745-6215

Howard, DR orcid.org/0000-0003-3333-9783, Munir, T, Hockaday, AM et al. (7 more authors) (2016) Chemotherapy plus Ofatumumab at Standard or Mega dose in relapsed CLL (COSMIC) trial: study protocol for a phase II randomised controlled trial. Trials, 17. 456. ISSN 1745-6215

Conference or Workshop Item

Oughton, JB orcid.org/0000-0002-2047-804X, Wright-Hughes, A orcid.org/0000-0001-8839-6756 and Dodwell, D (2014) When the LANTERN goes out: feasibility studies in a changing clinical environment. In: Society for Clinical Trials 35th Annual Meeting, 18-21 May 2014, Philadelphia, Pennsylvania, USA.

This list was generated on Sun Nov 24 15:25:56 2019 GMT.